Triple-negatives Mammakarzinom: Carboplatin hat klinischen Benefit in der Neoadjuvanz | Zendy

AI Assistant Blog Pricing

Open Access

Triple-negatives Mammakarzinom: Carboplatin hat klinischen Benefit in der Neoadjuvanz

Author(s) -

Nicola Siegmund-Schultze

Publication year - 2021

Publication title -

deutsches ärzteblatt

Language(s) - German

Resource type - Journals

eISSN - 0172-2107

pISSN - 0012-1207

DOI - 10.3238/persesmo.2021.10.22.01

Subject(s) - carboplatin , medicine , oncology , chemotherapy , cisplatin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.